CAS No |
Product Name |
Molecular Formula |
144649-99-0
|
5-Bromo-2-(methyloxy)benzonitrile;5-Bromo-2-methoxybenzonitrile
|
C8H6BrNO
|
144650-01-1
|
2,3-Dimethoxy-Benzenecarboximidamide
|
C9H13ClN2O2
|
144651-06-9
|
Oxasulfuron;Oxetan-3-yl 2-((4,6-dimethylpyrimidin-2-yl)carbamoylsulfamoyl)benzoate
|
C17H18N4O6S
|
144655-81-2
|
4-(2-Oxoimidazolidin-1-yl)benzonitrile
|
C10H9N3O
|
144657-65-8
|
2-Methyl-2-Propanyl 3-[(Dimethylamino)Methyl]-1H-Pyrrolo[2,3-b]Pyridine-1-Carboxylate
|
C15H21N3O2
|
144657-66-9
|
1-(tert-Butyloxycarbonyl)-3-formyl-7-azaindole
|
C13H14N2O3
|
144665-26-9
|
Diisopropoxybis(2,2,6,6-tetramethyl-3,5-heptanedionato)titanium
|
C28H52O6Ti
|
144675-82-1
|
Imidazo[1,2-a]Pyridine-8-Carboxamide
|
C8H7N3O
|
144675-97-8
|
Pixantrone dimaleate;6,9-Bis((2-aminoethyl)amino)benz(g)isoquinoline-5,10-dione (2Z)-2-butenedioate (1:2)
|
C17H19N5O2.2(C4H4O4)
|
144685-61-0
|
2-(Methylamino)-1-(1-Pyrrolidinyl)Ethanone
|
C7H14N2O
|
144688-69-7
|
2-Methyl-2-Propanyl 2-Methoxy-1-Pyrrolidinecarboxylate
|
C10H19NO3
|
144688-70-0
|
1-N-Boc-2-pyrrolidinonitrile;1-N-Boc-2-cyano-pyrrolidine; tert-Butyl 2-cyanopyrrolidine-1-carboxylate
|
C10H16N2O2
|
144689-23-6
|
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-carboxylic acid ethyl ester
|
C26H30N6O3
|
144689-24-7
|
Olmesartan;4-(1-Hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-carboxylic acid
|
C24H26N6O3
|
144689-63-4
|
Olmesartan medoxomil;Olmetec; CS-866; 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-carboxylic acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
|
C29H30N6O6
|
144689-93-0
|
Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate;4-(1-Hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylic acid ethyl ester
|
C12H20N2O3
|
144689-94-1
|
Diethyl 2-propylImidazoledicarbonate;2-Propyl-1H-imidazole-4,5-dicarboxylic acid diethyl ester
|
C12H18O4N2
|
144690-04-0
|
Olmesartan Impurity 17;4-(2-Hydroxypropan-2-yl)-2-propyl-1h-imidazole-5-carboxylic acid
|
C10H16N2O3
|
144690-33-5
|
Trityl olmesartan ethyl ester;4-(1-Hydroxy-1-methylethyl)-2-propyl-1-((2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-carboxylic acid ethyl ester
|
C45H44N6O3
|
144690-92-6
|
Trityl olmesartan;Trityl olmesartan medoxomil; 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-((2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
|
C48H44N6O6
|
144693-65-2
|
4-Ethynyl-Benzoic Acid Sodium Salt (1:1)
|
C9H5NaO2
|
144701-20-2
|
Fmoc-DL-Norleucine;Fmoc-DL-Nle-OH; Fmoc-DL-2-aminohexanoic acid
|
C21H23NO4
|
144701-24-6
|
Fmoc-D-Norvaline;Fmoc-D-2-aminovaleric acid; Fmoc-D-Nva-OH
|
C20H21NO4
|
144701-25-7
|
Fmoc-3-cyclohexyl-D-alanine;Fmoc-D-Cha-OH
|
C24H27NO4
|
144701-48-4
|
Telmisartan;4'((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)(1,1'-biphenyl)-2-carboxylic acid
|
C33H30N4O2
|
144702-26-1
|
4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)-methyl)-1,1'-biphenyl-2-carboxylic acid 1,1-dimethylethyl ester
|
C37H38N4O2
|
144702-27-2
|
4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carbonitrile
|
C33H29N5
|
144707-18-6
|
2-(2,3,4-Trihydroxyphenyl)-4H-1-benzopyran-4-one
|
C15H10O5
|
144740-54-5
|
Sodium (4,6-Dimethoxypyrimidin-2-Yl)Carbamoyl-[[3-Methoxycarbonyl-6-(Trifluoromethyl)-2-Pyridyl]Sulfonyl]Azanide
|
C15H13F3N5NaO7S
|
144750-42-5
|
alpha-(2-Chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetic acid hydrochloride
|
C15H14ClNO2S.HCl
|
144750-52-7
|
Clopidogrel Related Compound B;alpha-(2-Chlorophenyl)-4,7-dihydrothieno(2,3-c)pyridine-6(5H)-aceticacid methyl ester hydrochloride
|
C16H17Cl2NO2S
|
144783-46-0
|
1-(4-(4-Morpholinyl)-3-nitrophenyl)ethanone
|
C12H14N2O4
|
144796-70-3
|
TNF-α(10-36) (human);ASP-LYS-PRO-VAL-ALA-HIS-VAL-VAL-ALA-ASN-PRO-GLN-ALA-GLU-GLY-GLN-LEU-GLN-TRP-LEU-ASN-ARG-ARG-ALA-ASN-ALA-LEU
|
C131H211N43O38
|
144797-57-9
|
3,5-Difluoro-4-chlorobenzonitrile
|
C7H2ClF2N
|
144797-68-2
|
3,5-Difluorobenzamidine hydrochloride
|
C7H6F2N2.HCl
|
144799-02-0
|
3-Cyano-L-Phenylalanine
|
C10H10N2O2
|
144809-28-9
|
5-{4-(2-(5-Ethyl-2-pyridinyl)ethoxyl)benzylene}-2,4-thiazolidinedione
|
C19H18N2O3S
|
144835-67-6
|
2-Methylimidazo[3,2-a]Pyridine-3-Carbohydrazide
|
C9H10N4O
|
144851-59-2
|
2-Fluoro-6-(Trifluoromethyl)-Benzamide
|
C8H5F4NO
|
144851-61-6
|
2-Amino-3-fluorobenzotrifluoride;2-Fluoro-6-(trifluoromethyl)aniline
|
C7H5F4N
|
144851-62-7
|
2,6-Difluoro-3-Methoxyaniline
|
C7H7F2NO
|
144851-82-1
|
2-Amino-3-fluorobenzoic acid methyl ester
|
C8H8FNO2
|
144860-68-4
|
(2E,4S,5S,6E,8E)-10-[(2R,5S,7R,8S)-2-Butyl-2-{(1S,2E,4E)-5-Carboxy-1-[(3-Carboxypropanoyl)Oxy]-4-Methyl-2,4-Pentadien-1-Yl}-8-Methyl-1,6-Dioxaspiro[4.5]Dec-7-Yl]-5-Hydroxy-4,8-Dimethyl-2,6,8-Decatrien Oic Acid
|
C36H52O11
|
144860-69-5
|
(2E,4S,5S,6E,8E)-5-Hydroxy-10-[(3S,4R,6R,8S,10R)-10-[(1E,3E)-5-Hydroxy-3-Methyl-5-Oxo-Penta-1,3-Dienyl]-8-(4-Hydroxy-4-Oxo-Butanoyl)Oxy-8-Isopentyl-3-Methyl-5,11-Dioxaspiro[5.5]Undecan-4-Yl]-4,8-Dimethyl-Deca-2,6,8-Trienoic Acid
|
C37H54O11
|
144866-90-0
|
(1-Boc-7-azaindol-3-Methyl)triMethylaMMoniuM iodide
|
|
144868-17-7
|
(S)-2-Diphenyphosphino-2'-ethyl-1,1'-binaphthyl
|
C34H27P
|
144875-48-9
|
Resiquimod;4-Amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1H-imidazo(4,5-c)quinoline-1-ethanol; R-848; S 28463
|
C17H22N4O2
|
144876-20-0
|
2-Piperidinecarboxaldehyde
|
C6H11NO
|
144876-36-8
|
1H-Benzimidazole-4-carboxaldehyde;1H-Benzimidazole-7-carboxaldehyde
|
C8H6N2O
|
144876-37-9
|
1,3-Benzothiazole-7-Carbaldehyde
|
C8H5NOS
|